As a member of the Clinical Development group, the successful candidate will be responsible for conducting phase 1 studies related to clinical pharmacology (e.g., drug-drug interaction, food effect, BA/BE, and special population studies), interacting with regulatory agencies, and working with clinical science and other colleagues to optimize development plans and timing for clinical pipeline of 6-10 investigational drug products.